Final Study Completed for Cingulates Lead Asset CTx-1301

HOPHF Stock  USD 1.24  0.00  0.00%   
Roughly 55% of Hemogenyx Pharmaceuticals' stockholders are presently thinking to get in. The analysis of overall sentiment of trading Hemogenyx Pharmaceuticals Plc pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Hemogenyx Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Hemogenyx Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Hemogenyx Pharmaceuticals pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Hemogenyx daily returns and investor perception about the current price of Hemogenyx Pharmaceuticals Plc as well as its diversification or hedging effects on your existing portfolios.
  
No Serious Adverse Events ReportedSubmission of New Drug Application Targeted for Mid 2025 KANSAS CITY, Kan., Jan. 07, 2025 -- Cingulate

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  

Hemogenyx Pharmaceuticals Fundamental Analysis

We analyze Hemogenyx Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hemogenyx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hemogenyx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Hemogenyx Pharmaceuticals is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Hemogenyx Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hemogenyx Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Hemogenyx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Hemogenyx Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Hemogenyx Pharmaceuticals Related Equities

ELVNEnliven Therapeutics   1.22   
0%
10.0%
FENCFennec Pharmaceuticals   0.33   
2.0%
0%
CCCCC4 Therapeutics   0.52   
4.0%
0%
FHTXFoghorn Therapeutics   0.85   
7.0%
0%
MNPRMonopar Therapeutics   2.78   
23.0%
0%
STTKShattuck Labs   3.15   
26.0%
0%
INBXInhibrx   3.42   
28.0%
0%
CELCCelcuity LLC   4.44   
37.0%
0%
PMNProMIS Neurosciences   4.67   
39.0%
0%
GNLXGenelux Common   4.85   
40.0%
0%
PRLDPrelude Therapeutics   5.79   
48.0%
0%
QNRXQuoin Pharmaceuticals   6.06   
50.0%
0%
CVKDCadrenal Therapeutics,   7.23   
60.0%
0%
GLUEMonte Rosa   8.27   
69.0%
0%
CINGCingulate   8.30   
69.0%
0%
DYAIDyadic International   10.82   
90.0%
0%
SNTISenti Biosciences   11.96   
100.0%
0%

Complementary Tools for Hemogenyx Pink Sheet analysis

When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
FinTech Suite
Use AI to screen and filter profitable investment opportunities